Significance of CASP8AP2 and H2AFZ expression in survival and risk of relapse in children with acute lymphoblastic leukemia

References

• Rivera-Luna R, Correa-González C, Altamirano-Alvarez E, et al. Incidence of childhood cancer among Mexican children registered under a public medical insurance program. Int J Cancer 2013;132: 1646–1650.
   PubMed Web of Science ®Google Scholar
• Neale GAM, Campana D, Pui C-H. Minimal residual disease detection in acute lymphoblastic leukemia:real improvement with the real-time quantitative PCR method?J Pediatr Hematol Oncol 2003;25:100–102.
   PubMed Web of Science ®Google Scholar
• Pui C-H, Carroll WL, Meshinchi S, et al. Biology, risk stratification, and therapy of pediatric acute leukemias:an update. J Clin Oncol 2011;29:551–565.
   PubMed Web of Science ®Google Scholar
• Rivera-Luna R, Olaya-Vargas A, Velásquez-Aviña M, et al. Early death in children with acute lymphoblastic leukemia: does malnutrition play a role?Pediatr Hematol Oncol 2008;25:17–26.
   PubMed Web of Science ®Google Scholar
• Rabin K, Man T-K, Lau CC. Personalized care of pediatric cancer patients. Nestle Nutr Workshop Ser Pediatr Program 2008;62:173–188.
   PubMedGoogle Scholar
• Duffy MJ, Crown J. A personalized approach to cancer treatment: how biomarkers can help. Clin Chem 2008;54:1770–1779.
   PubMed Web of Science ®Google Scholar
• Izraeli S. Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia:from bench to bedside?Br J Haematol 2010;151:119–131.
   PubMed Web of Science ®Google Scholar
• Bhojwani D, Howard SC, Pui C-H. High-risk childhood acute lymphoblastic leukemia. Clin Lymphoma Myeloma 2009;9:S222–S230.
   PubMedGoogle Scholar
• Flotho C, Coustan-Smith E, Pei D, et al. Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2. Blood 2006;108:1050–1057.
   PubMed Web of Science ®Google Scholar
• Flotho C, Coustan-Smith E, Pei D, et al. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood 2007;110:1271–1277.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Cui L, Gao C, et al. CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia. Leuk Res 2012;36:67–71.
   PubMed Web of Science ®Google Scholar
• Juárez-Velázquez MR, Salas-Labadía C, Reyes-León A, et al. Genetic markers in the prognosis of childhood acute lymphoblastic leukemia. In: Mejia-Arangure JM, editor. Clinical epidemiology of acute lymphoblastic leukemia – from the molecules to the clinic. Rijeka, Croatia: In Tech; 2013. pp 193–235.
   Google Scholar
• Kittler R, Putz G, Pelletier L, et al. An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division. Nature 2004;432:1036–1040.
   PubMed Web of Science ®Google Scholar
• Choi YH, Kim KB, Kim HH, et al. FLASH coordinates NF-kappa B activity via TRAF2. J Biol Chem 2001;276 :25073–25077.
   PubMed Web of Science ®Google Scholar
• Alm-Kristiansen AH, Saether T, Matre V, et al. FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci. Oncogene 2008;27:4644–4656.
   PubMed Web of Science ®Google Scholar
• Alm-Kristiansen AH, Lorenzo PI, Molværsmyr A-K, et al. PIAS1 interacts with FLASH and enhances its co-activation of c-Myb. Mol Cancer 2011;10:21.
   PubMed Web of Science ®Google Scholar
• Barcaroli D, Dinsdale D, Neale MH, et al. FLASH is an essential component of Cajal bodies. Proc Natl Acad Sci USA 2006; 103:14802–14807.
   PubMed Web of Science ®Google Scholar
• Yang X, Xu B, Sabath I, et al. FLASH is required for the endonucleolytic cleavage of histone pre-mRNAs but is dispensable for the 5’ exonucleolytic degradation of the downstream cleavage product. Mol Cell Biol 2011;31:1492–1502.
   PubMed Web of Science ®Google Scholar
• Nekrasov M, Amrichova J, Parker BJ, et al. Histone H2A.Z inheritance during the cell cycle and its impact on promoter organization and dynamics. Nat Struct Mol Biol 2012;19:1076–1083.
   Google Scholar
• Soboleva TA, Nekrasov M, Pahwa A, et al. A unique H2A histone variant occupies the transcriptional start site of active genes. Nat Struct Mol Biol 2012;19:25–30.
   Google Scholar
• Greaves IK, Rangasamy D, Ridgway P, et al. H2A.Z contributes to the unique 3D structure of the centromere. Proc Natl Acad Sci USA 2007;104:525–530.
   PubMed Web of Science ®Google Scholar
• Huh YH, Sherley JL. Molecular cloaking of H2A.Z on mortal DNA chromosomes during nonrandom segregation. Stem Cells 2011;29:1620–1627.
   PubMed Web of Science ®Google Scholar
• Camitta BM. Colonel Mustard, with the rope, in the ballroom. Blood 2006;108:785.
   Web of Science ®Google Scholar
• Yang Y-L, Lin S-R, Chen J-S, et al. Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia. Leuk Res 2010;34:18–23.
   PubMed Web of Science ®Google Scholar
• Consejo Nacional para la Prevencion y el Tratamiento del Cancer en la Infancia y la Adolescencia. In: Rivera-Luna R, editor. Protocolos Técnicos Cancer en Niños. México, D.F.: Edamsa Impresiones S.A. de C.V.; 2010.
   Google Scholar
• Remke M, Pfister S, Kox C, et al. High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. Blood 2009;114:1053–1062.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Raimondi SC, Look AT, et al. Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. Blood 1990;76:1626–1630.
   PubMed Web of Science ®Google Scholar
• Takeuchi S, Koike M, Seriu T, et al. Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia. Cancer Res 1998;58:2618–2623.
   PubMed Web of Science ®Google Scholar
• Merup M, Moreno TC, Heyman M, et al. 6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas. Blood 1998;91:3397–3400.
   PubMed Web of Science ®Google Scholar
• Mancini M, Vegna ML, Castoldi GL, et al. Partial deletions of long arm of chromosome 6:biologic and clinical implications in adult acute lymphoblastic leukemia. Leukemia 2002;16:2055–2061.
   PubMed Web of Science ®Google Scholar
• Lee K-D, Pai M-Y, Hsu C-C, et al. Targeted Casp8AP2 methylation increases drug resistance in mesenchymal stem cells and cancer cells. Biochem Biophys Res Commun 2012;422:578–585.
   PubMed Web of Science ®Google Scholar
• Pérez-Cuevas R, Doubova SV, Zapata-Tarres M, et al. Scaling up cancer care for children without medical insurance in developing countries: the case of Mexico. Pediatr Blood Cancer 2013;60:196–203.
   PubMed Web of Science ®Google Scholar